|
|
||||||||
INFECTION IN INJECTING DRUG USERS |



Greater Glasgow NHS Board, Glasgow, *Scottish Centre for Infection and Environmental Health, Glasgow,
University of Glasgow, Glasgow,
Public Health Laboratory Service, London and Cardiff and
Glasgow Royal Infirmary, Glasgow, Scotland
Corresponding author: Dr C. McGuigan (e-mail: chris.mcguigan{at}fvhb.scot.nhs.uk).
Received 13 June 2002; accepted 4 July 2002.
Abstract
This report describes the investigation and management of an unprecedented outbreak of severe illness among injecting drug users (IDUs) in Scotland during April to August 2000. IDUs with severe soft tissue inflammation were prospectively sought among acute hospitals and a mortuary in Scotland. Cases were categorised as definite or probable: probable cases had severe injection site inflammation or multi-system failure; definite cases had both. Information about clinical course, mortality, post-mortem findings and laboratory data was gathered by standardised case-note review and interview. Sixty cases were identified 23 definite and 37 probable. Most had familial or social links with each other and 50 were from Glasgow. Median age was 30 years; 31 were female. The majority, especially definite cases, injected heroin/citric acid extravascularly. Of definite cases, 20 died (87% case-fatality rate; 13 after intensive care), 15 had necrotising fasciitis, 22 had injection site oedema and 13 had pleural effusion. Median white cell count was 60x109/L. Of 37 probable cases, three died (8% case-fatality rate). Overall, the most frequently isolated pathogen was Clostridium novyi type A (13 cases: 8 in definite cases). The findings are consistent with an infection resulting from injection into soft tissue of acidified heroin contaminated with spore-forming bacteria. Toxin production led to a severe local reaction and, in many, multi-system failure.
This article has been cited by other articles:
![]() |
E. M. Gardner, M. Kestler, A. Beieler, and R. W. Belknap Clostridium butyricum sepsis in an injection drug user with an indwelling central venous catheter J. Med. Microbiol., February 1, 2008; 57(2): 236 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heffron and I. R. Poxton A PCR approach to determine the distribution of toxin genes in closely related Clostridium species: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridium novyi {alpha} toxin J. Med. Microbiol., February 1, 2007; 56(2): 196 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Diaz Jr., I. Cheong, C. A. Foss, X. Zhang, B. A. Peters, N. Agrawal, C. Bettegowda, B. Karim, G. Liu, K. Khan, et al. Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores Toxicol. Sci., December 1, 2005; 88(2): 562 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stewart, J. Cowden, J. McMenamin, and B. Reilly Veterinary public health BMJ, November 26, 2005; 331(7527): 1213 - 1214. [Full Text] [PDF] |
||||
![]() |
D. Akbulut, K. A. Grant, and J. McLauchlin Improvement in Laboratory Diagnosis of Wound Botulism and Tetanus among Injecting Illicit-Drug Users by Use of Real-Time PCR Assays for Neurotoxin Gene Fragments J. Clin. Microbiol., September 1, 2005; 43(9): 4342 - 4348. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Agrawal, C. Bettegowda, I. Cheong, J.-F. Geschwind, C. G. Drake, E. L. Hipkiss, M. Tatsumi, L. H. Dang, L. A. Diaz Jr., M. Pomper, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors PNAS, October 19, 2004; 101(42): 15172 - 15177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Brett, G. Hallas, and O. Mpamugo Wound botulism in the UK and Ireland J. Med. Microbiol., June 1, 2004; 53(6): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.S. BRAZIER, B.I. DUERDEN, V. HALL, J.E. SALMON, J. HOOD, M.M. BRETT, J. MCLAUCHLIN, and R.C. GEORGE Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team J. Med. Microbiol., November 1, 2002; 51(11): 985 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. MCLAUCHLIN, J.E. SALMON, S. AHMED, J.S. BRAZIER, M.M. BRETT, R.C. GEORGE, and J. HOOD Amplified fragment length polymorphism (AFLP) analysis of Clostridium novyi, C. perfringens and Bacillus cereus isolated from injecting drug users during 2000 J. Med. Microbiol., November 1, 2002; 51(11): 990 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McLAUCHLIN, V. MITHANI, F.J. BOLTON, G.L. NICHOLS, M.A. BELLIS, Q. SYED, R.P. M. THOMSON, and J.R. ASHTON An investigation into the microflora of heroin J. Med. Microbiol., November 1, 2002; 51(11): 1001 - 1008. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |